Seborrheic dermatitis: many natural remedies for skin inflammation

In brief

• Seborrheic dermatitis is a chronic inflammatory condition affecting areas rich in sebaceous glands; the yeast Malassezia is often associated with the disease.
• Therapies with the best evidence include topical antifungals (e.g., ketoconazole) and, for flare-ups, topical anti-inflammatory agents; the choice depends on location and severity.
• Some "natural" remedies (specific shampoos, ingredients with antifungal or soothing action) can help alone or as support, but clinical evidence is often limited.
• Factors such as immunosuppression (HIV), neurological diseases (Parkinson's), or stress can influence frequency and severity; management is individual and usually long-term.

Abstract: what does science say?

Seborrheic dermatitis is a chronic inflammatory disease affecting the skin and scalp in sebum-rich areas. Evidence indicates that the proliferation of Malassezia yeasts and the individual immune response contribute to the clinical picture; however, the relationship is complex and multifactorial. Clinical studies and systematic reviews show that topical antifungals (e.g., azole-based shampoos or creams) reduce signs and symptoms in most patients and are a central component of treatment. Topical anti-inflammatory drugs (corticosteroids or calcineurin inhibitors) are effective in flare-ups but require caution due to long-term effects. Interventions such as phototherapy have limited data but may be useful in selected cases. Regarding natural remedies and supplements—for example, omega-3 rich oils, some plant extracts, or natural antimicrobial preparations—biological plausibility exists, but robust clinical evidence is scarce or inconsistent. In general, the choice of treatment depends on the location (face, scalp, folds), severity, and any comorbidities; an individual assessment and a long-term approach aimed at symptom control rather than definitive "cure" are necessary. The main limitations of current knowledge are variability between studies, the scarcity of high-quality trials on some natural remedies, and the heterogeneity of outcome definitions.

What it means in practice

In everyday language, seborrheic dermatitis manifests as redness, scaling, and itching in areas such as the scalp, eyebrows, nasolabial folds, retroauricular area, and chest. In practice: control involves targeted local treatments and maintenance strategies. Topical antifungals (shampoos or creams) are the first tool to consider for reducing Malassezia growth and controlling scales; regular and intermittent use can prevent relapses. In cases of marked inflammation, short courses of topical anti-inflammatories are used under medical supervision. Some daily care measures (gentle cleansers, non-comedogenic emollients, avoiding irritating cosmetics) help skin tolerability. Seasonal variations (improvement in summer, worsening in winter), stress, and systemic conditions or medications can influence the frequency of flare-ups; therefore, the management plan is often personalized. Natural remedies and supplements can play a complementary role but do not replace evidence-based therapies; discussing them with a doctor is advisable, especially if systemic products are being taken or if there are relevant clinical conditions. If symptoms are severe, widespread, or resistant, it is appropriate to consult a dermatologist to rule out other pathologies and adjust therapy safely.

Clinical-scientific insights

What is seborrheic dermatitis and where does it affect?

Seborrheic dermatitis is an inflammatory dermatitis that prefers sebaceous areas: scalp, eyebrows, nasolabial folds, retroauricular area, sternal and interscapular regions. The picture varies from mild scaling (dandruff) to more evident and itchy erythematous plaques. The disease can appear in infants (cradle cap), adolescence, and middle age; epidemiological reports estimate a significant prevalence in the general population, with fluctuations by age and clinical context [1]. Diagnosis is clinical and often based on the appearance and distribution of lesions; laboratory tests are rarely needed unless there are diagnostic doubts or suspicion of superinfection.

Why it develops: role of sebum, microbiome, and immune system

Research indicates that the excessive or altered presence of sebum is not the only problem: rather, the quality of the skin's lipid film, microbial composition, and individual immune response are key elements. Malassezia yeasts, normally present on the skin, can proliferate excessively and promote inflammation through immunomodulatory mechanisms and the production of enzymes that alter the skin barrier [2]. Individual susceptibility is influenced by genetic factors, skin barrier variants, hormonal alterations, and systemic conditions that modify immunity. In immunocompromised individuals or those with neurological diseases, some forms can be more severe or recurrent [5][6].

Signs and symptoms: how to recognize them

Typical signs are: redness, oily/greasy scaling on the scalp or facial skin, variable itching, and sometimes a burning sensation or discomfort. Dandruff is a milder form; dermatitis is distinguished by larger scales associated with underlying erythema. Severity is assessed based on extent, impact on quality of life, and response to topical treatments. When thick crusts or signs of secondary infection (e.g., discharge, pain) are present, medical attention is necessary.

Treatments with the best evidence: topical antifungals and anti-inflammatories

Systematic reviews and guidelines indicate topical antifungals as the cornerstone of treatment: shampoos containing azoles (e.g., ketoconazole) or creams with antifungal active ingredients reduce signs and symptoms and are useful for both acute control and intermittent maintenance therapy [3][4]. Low-potency topical corticosteroids are effective in rapidly reducing inflammation during flare-ups, but their prolonged use can cause local adverse effects; non-steroidal alternatives, such as calcineurin inhibitors, are options in some sensitive areas. The choice between these options must consider the location, duration, and severity of the disease, as well as patient preferences and the local risks of each treatment [3].

Natural remedies and supplements: what the evidence says

Many natural products (plant extracts with antimicrobial or soothing activity, essential oils, shampoos based on ciclopirox, zinc pyrithione, or tar) are used for scaling control. Some formulations show benefits in limited clinical studies; however, the methodological quality is often lower than that of pharmacological trials. Omega-3 fatty acids have biological plausibility for modulating skin inflammation, and scientific reviews indicate potential beneficial effects on the skin, but specific data for seborrheic dermatitis are scarce and inconclusive [8]. Therefore, such approaches can be considered complementary but not a substitute for therapies with consolidated evidence.

Phototherapy and other non-pharmacological options

Phototherapy (narrowband UVB or UVA1) has been used in selected cases with variable results; reviews indicate limited but potentially useful data for widespread or resistant forms, always evaluating long-term risks and benefits [7]. Hygienic measures and cosmetic choices—non-irritating cleansers, suitable emollients, avoiding comedogenic products—are useful for improving symptoms and skin tolerability in daily life.

Key takeaways

• Malassezia is often involved, but the disease is multifactorial; individual response is crucial [2].
• Topical antifungals (shampoos/creams) have the best evidence for controlling signs and symptoms; ketoconazole is among the most studied [3][4].
• For flare-ups, topical anti-inflammatories are useful but require prudent use due to local effects [3].
• Natural remedies and supplements can help as support, but evidence is limited and variable [8].
• Systemic conditions (HIV, Parkinson's) and stress can worsen the disease; management should be personalized [5][6].

Limitations of evidence

Available evidence includes systematic reviews, clinical, and observational studies; however, limitations remain. Observational studies can show associations (e.g., between SD and Parkinson's or HIV) but do not prove causality [5][6]. Many studies on natural remedies are small, heterogeneous in formulation and reported outcomes, which limits generalizability. Definitions of severity and assessment tools also differ between studies. Consequently, recommendations must be interpreted with caution and contextualized to the individual patient.

Editorial conclusion

Seborrheic dermatitis is common, recurrent, and has a variable impact on quality of life. Clinical literature supports the use of topical antifungals as a first therapeutic approach, supplemented by anti-inflammatory measures for flare-ups. Numerous natural remedies and complementary practices have biological plausibility and can provide benefit in some cases, but the robustness of the evidence varies and does not always meet the standards of pharmacological trials. For patients, the most reasonable path is personalized management, agreed upon with a doctor or dermatologist, prioritizing interventions with consolidated evidence and a maintenance plan to reduce relapses.

Editorial note

Article originally published in the past and updated according to scientific and divulgative criteria. The purpose is informative and does not replace individual medical advice. For diagnosis, prescriptions, and therapeutic management, consult a qualified doctor or dermatologist. (If necessary, consult updated clinical sources or national guidelines.)

Scientific research

1. van der Heijden JP, et al. The Global Prevalence of Seborrheic Dermatitis: A Systematic Review and Meta‑Analysis. JAMA Dermatol. 2024. https://doi.org/10.1001/jamadermatol.2024.1987
2. Saunte DML, Gaitanis G, Hay RJ. Malassezia‑Associated Skin Diseases, the Use of Diagnostics and Treatment. Front Cell Infect Microbiol. 2020;10:112. https://doi.org/10.3389/fcimb.2020.00112
3. Cochrane Skin Group. Topical antifungals for seborrhoeic dermatitis. Cochrane Database Syst Rev. 2014;CD009446. https://doi.org/10.1002/14651858.CD009446.pub2
4. Choi FD, Juhasz MLW, Atanaskova‑Mesinkovska N. Topical ketoconazole: a systematic review of current dermatological applications and future developments. J Dermatolog Treat. 2019;30(8):760‑771. https://doi.org/10.1080/09546634.2019.1573309
5. Soares M, et al. Prevalence of Malassezia species on the skin of HIV‑seropositive patients. Sci Rep. 2020;10:17779. https://doi.org/10.1038/s41598-020-74133-6
6. Laurence M, Benito‑León J, Calon F. Malassezia and Parkinson’s Disease. Front Neurol. 2019;10:758. https://doi.org/10.3389/fneur.2019.00758
7. Phototherapy review: Narrowband UVB and other modalities—overview and applications. An Bras Dermatol. 2021. https://doi.org/10.1016/j.abd.2021.03.001
8. Huang T‑H, Wang P‑W, Yang S‑C, et al. Cosmetic and Therapeutic Applications of Fish Oil’s Fatty Acids on the Skin. Mar Drugs. 2018;16(8):256. https://doi.org/10.3390/md16080256
9. Gaitanis G, et al. A laboratory‑based study on patients with Parkinson's disease and seborrheic dermatitis: presence and density of Malassezia yeasts. BMC Dermatol. 2014;14:5. https://doi.org/10.1186/1471-5945-14-5
10. Treatment review: comprehensive review on current options for seborrheic dermatitis. J Dermatolog Treat. 2018; https://doi.org/10.1080/09546634.2018.1473554

Editorial transparency: update carried out with consultation of systematic reviews, reviews, and primary studies indicated in the bibliography. No references without verifiable DOI were included. No ORCIDs of the original authors are present in the source text.